Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Procaps Group ( (PROC) ) has shared an update.
On January 10, 2025, Procaps Group, a leading player in the pharmaceutical and healthcare industry, appointed Mr. Jorddy Antonio Pérez Galindo as a new Director and Chairman of the Audit Committee, filling the vacancy left by Mr. David Yanovich’s resignation in December 2024. This strategic appointment, acknowledging Mr. Pérez Galindo’s extensive experience in finance and accounting, aims to strengthen the company’s governance and ensure compliance with regulatory standards, potentially reinforcing stakeholders’ confidence in Procaps Group’s financial oversight.
More about Procaps Group
YTD Price Performance: -25.32%
Average Trading Volume: 105,102
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $198.6M
For a thorough assessment of PROC stock, go to TipRanks’ Stock Analysis page.
